The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...

GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...

A recent study discovered that individuals using GLP-1 medications may develop severe acid reflux.Researchers discovered that ...

Nationwide shutdown called as tensions rise over police allegations Should Audi, Mercedes, and BMW Be Worried? Nio ET9 Luxury ...

In older patients with cancer and type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with ...

All About Sarah Jessica Parker’s Son James and Twins Tabitha and Marion (Who Didn’t Know She Was Famous) Leavitt Gets ...

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.

Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

Aureus Asset Management, an $8 billion registered investment advisor in Boston, has been recommending alternative investments ...

GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...